GLP1 S

Sold by case = 10 vials

Semaglutide

For Research Use Only. Not for Human or Veterinary Consumption.

Commonly marketed as Semaglutide, this is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist studied extensively in laboratory research for its effects on glucose metabolism and appetite regulation. Researchers utilize Semaglutide to investigate mechanisms of GLP-1 receptor activation, insulin secretion modulation, and energy balance in experimental models. This peptide supports advanced studies into metabolic pathways and endocrine signaling related to glucose homeostasis.

This compound is intended exclusively for qualified laboratory research. Not approved for therapeutic, diagnostic, or human use.

Mechanism of Action

• Activates GLP-1 receptors to enhance glucose-dependent insulin secretion in laboratory models.

• Inhibits glucagon release and slows gastric emptying to support appetite regulation in experimental research.

• Investigated for modulation of energy balance and weight regulation through central and peripheral pathways.

• Explored for improving glycemic control and metabolic function in controlled settings.